BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 20956481)

  • 1. Brief intraperitoneal radioimmunotherapy of small peritoneal carcinomatosis using high activities of noninternalizing 125I-labeled monoclonal antibodies.
    Boudousq V; Ricaud S; Garambois V; Bascoul-Mollevi C; Boutaleb S; Busson M; Quenet F; Colombo PE; Bardiès M; Kotzki PO; Navarro-Teulon I; Pèlegrin A; Pouget JP
    J Nucl Med; 2010 Nov; 51(11):1748-55. PubMed ID: 20956481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninternalizing monoclonal antibodies are suitable candidates for 125I radioimmunotherapy of small-volume peritoneal carcinomatosis.
    Santoro L; Boutaleb S; Garambois V; Bascoul-Mollevi C; Boudousq V; Kotzki PO; Pèlegrin M; Navarro-Teulon I; Pèlegrin A; Pouget JP
    J Nucl Med; 2009 Dec; 50(12):2033-41. PubMed ID: 19910417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretargeted radioimmunotherapy and SPECT imaging of peritoneal carcinomatosis using bioorthogonal click chemistry: probe selection and first proof-of-concept.
    Rondon A; Schmitt S; Briat A; Ty N; Maigne L; Quintana M; Membreno R; Zeglis BM; Navarro-Teulon I; Pouget JP; Chezal JM; Miot-Noirault E; Moreau E; Degoul F
    Theranostics; 2019; 9(22):6706-6718. PubMed ID: 31588245
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison between internalizing anti-HER2 mAbs and non-internalizing anti-CEA mAbs in alpha-radioimmunotherapy of small volume peritoneal carcinomatosis using 212Pb.
    Boudousq V; Bobyk L; Busson M; Garambois V; Jarlier M; Charalambatou P; Pèlegrin A; Paillas S; Chouin N; Quenet F; Maquaire P; Torgue J; Navarro-Teulon I; Pouget JP
    PLoS One; 2013; 8(7):e69613. PubMed ID: 23922757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin.
    Koppe MJ; Bleichrodt RP; Soede AC; Verhofstad AA; Goldenberg DM; Oyen WJ; Boerman OC
    J Nucl Med; 2004 Jul; 45(7):1224-32. PubMed ID: 15235070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative immuno-SPECT monitoring of pretargeted radioimmunotherapy with a bispecific antibody in an intraperitoneal nude mouse model of human colon cancer.
    Schoffelen R; van der Graaf WT; Sharkey RM; Franssen GM; McBride WJ; Chang CH; Bos DL; Goldenberg DM; Oyen WJ; Boerman OC
    J Nucl Med; 2012 Dec; 53(12):1926-32. PubMed ID: 23081995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioimmunotherapy is an effective adjuvant treatment after cytoreductive surgery of experimental colonic peritoneal carcinomatosis.
    Koppe MJ; Hendriks T; Boerman OC; Oyen WJ; Bleichrodt RP
    J Nucl Med; 2006 Nov; 47(11):1867-74. PubMed ID: 17079821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiolabeled Antibodies Against Müllerian-Inhibiting Substance Receptor, Type II: New Tools for a Theranostic Approach in Ovarian Cancer.
    Deshayes E; Ladjohounlou R; Le Fur P; Pichard A; Lozza C; Boudousq V; Sevestre S; Jarlier M; Kashani R; Koch J; Sosabowski J; Foster J; Chouin N; Bruchertseifer F; Morgenstern A; Kotzki PO; Navarro-Teulon I; Pouget JP
    J Nucl Med; 2018 Aug; 59(8):1234-1242. PubMed ID: 29674421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 211At radioimmunotherapy of subcutaneous human ovarian cancer xenografts: evaluation of relative biologic effectiveness of an alpha-emitter in vivo.
    Bäck T; Andersson H; Divgi CR; Hultborn R; Jensen H; Lindegren S; Palm S; Jacobsson L
    J Nucl Med; 2005 Dec; 46(12):2061-7. PubMed ID: 16330571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic efficacy and tumor dose estimations in radioimmunotherapy of intraperitoneally growing OVCAR-3 cells in nude mice with (211)At-labeled monoclonal antibody MX35.
    Elgqvist J; Andersson H; Bäck T; Hultborn R; Jensen H; Karlsson B; Lindegren S; Palm S; Warnhammar E; Jacobsson L
    J Nucl Med; 2005 Nov; 46(11):1907-15. PubMed ID: 16269606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental radioimmunotherapy of small peritoneal metastases of colorectal origin.
    Koppe MJ; Soede AC; Pels W; Oyen WJ; Goldenberg DM; Bleichrodt RP; Boerman OC
    Int J Cancer; 2003 Oct; 106(6):965-72. PubMed ID: 12918078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cure of Human Ovarian Carcinoma Solid Xenografts by Fractionated α-Radioimmunotherapy with
    Bäck T; Chouin N; Lindegren S; Kahu H; Jensen H; Albertsson P; Palm S
    J Nucl Med; 2017 Apr; 58(4):598-604. PubMed ID: 27688477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraperitoneal radioimmunotherapy in treating peritoneal carcinomatosis of colon cancer in mice compared with systemic radioimmunotherapy.
    Kinuya S; Li XF; Yokoyama K; Mori H; Shiba K; Watanabe N; Shuke N; Bunko H; Michigishi T; Tonami N
    Cancer Sci; 2003 Jul; 94(7):650-4. PubMed ID: 12841877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B7H3-Directed Intraperitoneal Radioimmunotherapy With Radioiodinated Omburtamab for Desmoplastic Small Round Cell Tumor and Other Peritoneal Tumors: Results of a Phase I Study.
    Modak S; Zanzonico P; Grkovski M; Slotkin EK; Carrasquillo JA; Lyashchenko SK; Lewis JS; Cheung IY; Heaton T; LaQuaglia MP; Cheung NV; Pandit-Taskar N
    J Clin Oncol; 2020 Dec; 38(36):4283-4291. PubMed ID: 33119478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of HER2-Targeted Intraperitoneal
    Chung SK; Vargas DB; Chandler CS; Katugampola S; Veach DR; McDevitt MR; Seo SH; Vaughn BA; Rinne SS; Punzalan B; Patel M; Xu H; Guo HF; Zanzonico PB; Monette S; Yang G; Ouerfelli O; Nash GM; Cercek A; Fung EK; Howell RW; Larson SM; Cheal SM; Cheung NV
    J Nucl Med; 2023 Sep; 64(9):1439-1445. PubMed ID: 37348919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy using the cyclooxygenase-2 inhibitor Parecoxib and radioimmunotherapy in nude mice with small peritoneal metastases of colonic origin.
    Koppe MJ; Oyen WJ; Bleichrodt RP; Hendriks T; Verhofstad AA; Goldenberg DM; Boerman OC
    Cancer Immunol Immunother; 2006 Jan; 55(1):47-55. PubMed ID: 15868166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
    Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 213Bi radioimmunotherapy with an anti-mCD138 monoclonal antibody in a murine model of multiple myeloma.
    Chérel M; Gouard S; Gaschet J; Saï-Maurel C; Bruchertseifer F; Morgenstern A; Bourgeois M; Gestin JF; Bodéré FK; Barbet J; Moreau P; Davodeau F
    J Nucl Med; 2013 Sep; 54(9):1597-604. PubMed ID: 24003167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetry results suggest feasibility of radioimmunotherapy using anti-CD138 (B-B4) antibody in multiple myeloma patients.
    Rousseau C; Ferrer L; Supiot S; Bardiès M; Davodeau F; Faivre-Chauvet A; Baumgartner P; Wijdenes J; Lacombe M; Barbet J; Guillaume T; Moreau P; Harousseau JL; Kraeber-Bodéré F; Cherel M
    Tumour Biol; 2012 Jun; 33(3):679-88. PubMed ID: 22389160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 177Lu-immunotherapy of experimental peritoneal carcinomatosis shows comparable effectiveness to 213Bi-immunotherapy, but causes toxicity not observed with 213Bi.
    Seidl C; Zöckler C; Beck R; Quintanilla-Martinez L; Bruchertseifer F; Senekowitsch-Schmidtke R
    Eur J Nucl Med Mol Imaging; 2011 Feb; 38(2):312-22. PubMed ID: 21072513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.